Does Metamizole Cause Less Acute Kidney Injury than Non-Steroidal Anti-Inflammatory Drugs When Combined with Diuretics and Antihypertensives?
Open Access
Abstract
The concurrent use of (a) diuretics, (b) renin–angiotensin–aldosterone system inhibitors (RAASIs), and (c) non-steroidal anti-inflammatory drugs (NSAIDs) or metamizole, known as the triple whammy (TW) combination, increases the risk of acute kidney injury (AKI). This study compared TWs including metamizole versus NSAIDs regarding hospitalisation for AKI, need for renal replacement therapy (RRT), and all-cause mortality during hospitalisation. Serum creatinine (sCr) and estimated glomerular filtration rate (eGFR) changes in the first year after TW initiation were also assessed. A nested case–control study was conducted within a cohort of adults receiving TW therapy (2009–2018). Logistic regression models analysed the associations between TW type and outcomes. Among 65,077 individuals (mean age 79.7 years; 26.3% male), TW including an NSAID was associated with a lower risk of AKI-related hospitalisation [adjusted odds ratio (aOR) 0.81, 95%CI 0.74–0.87] and all-cause mortality (aOR 0.64, 95%CI 0.49–0.82) compared to TW including metamizole. No significant differences were found in other variables. These findings suggest that TW including an NSAID may reduce the risk of AKI-related hospitalisation and mortality compared to TW including metamizole, although kidney function parameters remained unaffected. Further research is needed to confirm these results.Keywords
Funding Information
- Government of Navarre (Spain)
- European Regional Development Fund (ERDF)
This publication has 14 references indexed in Scilit:
- Acute kidney injury related to metamizole in advanced chronic liver disease patients undergoing major orthopedic surgeryJournal of Hepatology, 2023
- Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control studyPharmacoepidemiology and Drug Safety, 2023
- A cross-sectional exploratory survey on occurrence of triple-whammy prescription pattern in JapanInternational Journal of Clinical Pharmacy, 2020
- Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in SpainPharmacoepidemiology and Drug Safety, 2020
- The Concomitant Use of Diuretics, Non-Steroidal Anti-Inflammatory Drugs, and Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (Triple Whammy), Extreme Heat, and In-Hospital Acute Kidney Injury in Older Medical PatientsAdvances in Therapy, 2017
- The use of dipyrone in the ICU is associated with acute kidney injuryEuropean Journal of Anaesthesiology, 2017
- Intervención farmacéutica para reducir el riesgo de iatrogenia asociada a la combinación triple whammyAtencion Primaria, 2017
- Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injuryKidney International, 2015
- Fracaso renal agudo secundario a combinación de inhibidores del sistema renina-angiotensina, diuréticos y AINES. “La Triple Whammy”1Nefrología, 2015
- Drug interactions between antihypertensive drugs and non‐steroidal anti‐inflammatory agents: a descriptive study using the French Pharmacovigilance databaseFundamental & Clinical Pharmacology, 2012